Low density lipoproteins of male donors decrease prostacyclin (PGI2) and enhance thromboxane (TXA2) release from rat...

Area of Science:

• Cardiovascular Biology
• Lipid Metabolism
• Eicosanoid Biochemistry

Background:

• Elevated low-density lipoprotein (LDL) cholesterol is a major risk factor for atherosclerosis.
• Lipoproteins influence vascular function and inflammation.
• Eicosanoids, such as thromboxane A2 (TXA2) and prostacyclin (PGI2), play critical roles in regulating vascular tone and platelet aggregation.

Purpose of the Study:

• To investigate the impact of LDL and HDL cholesterol on eicosanoid production in rat aortas.
• To determine how LDL and HDL affect the balance between pro-aggregatory and anti-aggregatory eicosanoids.

Main Methods:

• Rat aortas were perfused under pulsatile pressure with solutions containing specific concentrations of LDL and HDL cholesterol.
• Levels of 6-oxo-PGF1α (a stable metabolite of PGI2) and TXB2 (a stable metabolite of TXA2) in the perfusates were measured.
• Changes in lipoprotein concentrations and eicosanoid levels were analyzed.

Main Results:

• LDL-cholesterol concentration decreased significantly after passage through the aortas.
• LDL significantly reduced 6-oxo-PGF1α levels by over 50% and increased TXB2 levels by approximately 50%.
• HDL-cholesterol levels remained unchanged, and HDL did not significantly alter the ratio of these eicosanoids.

Conclusions:

• LDL at the studied concentration enhances the formation of pro-aggregatory TXA2 and decreases the formation of anti-aggregatory PGI2 in rat aortas.
• The observed changes in eicosanoid metabolism by LDL may contribute to the pro-aggregatory effects of elevated LDL during atherosclerosis development.
• Vascular wall eicosanoid metabolism is a potential mechanism through which LDL exerts its atherogenic influence.